MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$1,019K
Net Income
-$2,555K
Net Profit Margin
-250.74%
Unit: Thousand (K) dollars
Revenue Breakdown
Service
US
Europe
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenues
1,019
432
-
-
Product
22
31
-
-
Revenues
-
-
238
226
Service
899
11
-
-
Total cost of revenues
921
42
20
18
Gross profit
98
390
218
208
Selling, general and administrative
3,911
2,559
2,756
2,953
Research and development
142
149
328
276
Acquired in-process research and development
0
0
0
0
Loss on impairment of intangible assets
-
-
6,995
-
Total operating expenses
4,053
2,708
10,079
3,229
Operating loss
-3,955
-2,318
-9,861
-3,021
Interest income
4
2
3
10
Interest expense-Nonrelated Party
161
76
-10*
35
Interest expense-Related Party
43
43
42*
48
Change in fair value of royalties payable due to related parties
0
0
7,813
726
Change in fair value of trading debt securities
0
-
-739*
107
Change in fair value of minority equity interest
0
-2,302
-
-
Change in fair value of convertible notes payable
-
-
1*
-
Change in fair value of deferred consideration
318
2,877
-
-
Loss on debt extinguishment
-105
-
-3,253*
-
Unrealized gains and losses on marketable securities, net
378
-
-
-
Other expenses, net
-54
-5
7*
-5
Total other income (expense), net
337
453
3,799
755
Loss from operations before income tax benefit
-3,618
-1,865
-6,062
-2,266
Income tax benefit
-312
-175
-214
78
Net loss
-3,306
-1,690
-5,627*
-2,344
Less net gain attributable to non-controlling interest
-11
-9
151*
-93
Net loss attributable to catheter precision, inc
-3,295
-1,681
-5,778
-2,251
Deemed dividend on warrant inducement offer
0
1,360
0
-
Deemed contribution on extinguishment of preferred stock
-740
-
-
-
Net loss attributable to catheter precision, inc. common stockholders
-2,555
-3,041
-5,778
-
Basic EPS
-0.92
-1.39
-5.347
-1.7
Basic Average Shares
2,767,440
2,191,831
1,080,617*
1,320,554
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
attributable to catheter...
-$2,555K
Deemed contribution on
extinguishment of preferred...
-$740K
Net loss
attributable to catheter...
-$3,295K
(35.51%↑ Y/Y)
Less net gain
attributable to...
-$11K
(96.85%↑ Y/Y)
US
$210K
(21.39%↑ Y/Y)
Europe
$60K
(53.85%↑ Y/Y)
Net loss
-$3,306K
(39.43%↑ Y/Y)
Income tax benefit
-$312K
(67.16%↑ Y/Y)
Unrealized gains and losses
on marketable...
$378K
Service
$749K
Product
$270K
Change in fair value of
deferred consideration
$318K
Interest income
$4K
(33.33%↑ Y/Y)
Loss from operations
before income tax...
-$3,618K
(43.54%↑ Y/Y)
Total other income
(expense), net
$337K
(119.57%↑ Y/Y)
Revenues
$1,019K
Interest
expense-Nonrelated Party
$161K
Loss on debt
extinguishment
-$105K
Other expenses, net
-$54K
(-5300.00%↓ Y/Y)
Interest
expense-Related Party
$43K
Operating loss
-$3,955K
(15.60%↑ Y/Y)
Gross profit
$98K
(-50.51%↓ Y/Y)
Total cost of revenues
$921K
(6478.57%↑ Y/Y)
Total operating
expenses
$4,053K
(-17.01%↓ Y/Y)
Service
$899K
Product
$22K
Selling, general and
administrative
$3,911K
(35.75%↑ Y/Y)
Research and development
$142K
(-8.39%↓ Y/Y)
Buy us a coffee
Catheter Precision, Inc. (VTAK)
Catheter Precision, Inc. (VTAK)